Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis
Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its exec...
Saved in:
Published in | Redox report : communications in free radical research Vol. 28; no. 1; p. 2152607 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
31.12.2023
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity. |
---|---|
AbstractList | Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity. Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity. ABSTRACTRenal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity. Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity. Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity. |
Author | Chu, Li-Kai Cao, Xu Bi, Yun-Li Liu, Jun Yan, Xiang-Ming Dong, Xing-Qiang Mao, Yi-Ming Xiong, Qian-Wei Chen, Ching-Hsien |
Author_xml | – sequence: 1 givenname: Xing-Qiang surname: Dong fullname: Dong, Xing-Qiang organization: Children's Hospital of Soochow University – sequence: 2 givenname: Li-Kai surname: Chu fullname: Chu, Li-Kai organization: Children's Hospital of Soochow University – sequence: 3 givenname: Xu surname: Cao fullname: Cao, Xu organization: Children's Hospital of Soochow University – sequence: 4 givenname: Qian-Wei surname: Xiong fullname: Xiong, Qian-Wei organization: Children's Hospital of Soochow University – sequence: 5 givenname: Yi-Ming surname: Mao fullname: Mao, Yi-Ming organization: Shanghai Jiao Tong University School of Medicine – sequence: 6 givenname: Ching-Hsien surname: Chen fullname: Chen, Ching-Hsien organization: University of California Davis – sequence: 7 givenname: Yun-Li surname: Bi fullname: Bi, Yun-Li organization: Children's Hospital of Soochow University – sequence: 8 givenname: Jun orcidid: 0000-0002-0917-7449 surname: Liu fullname: Liu, Jun email: junliu@suda.edu.cn, xm_yan0302@suda.edu.cn organization: Pediatric Institute of Soochow University, Children's Hospital of Soochow University – sequence: 9 givenname: Xiang-Ming surname: Yan fullname: Yan, Xiang-Ming organization: Children's Hospital of Soochow University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36692085$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUstu1TAUjFARfcAngLJkk-JH4thCQqCqlEqV2MDaOvHj1pVjB9tp1b_Ht_e2oixg48fxzBzbM8fNQYjBNM1bjE4x4ugDpgNGCJFTgkgd8EAYGl80R3jsaUcE4Qd1XTHdFnTYHOd8U1eUCf6qOaSMCYL4cNTEC78WKNeuqrezKTBF7_LcJnPnkgubdkmxGFVyrQTwbVmn1ZtWGe9zCxtwIZdWubx4KC50LuhVGd3CEpcSs6uYoFtrUtrvXzcvLfhs3uznk-bn1_MfZ9-6q-8Xl2dfrjrFECodRRQNpleIM82FolYjTKklIChGdqSAGVF26KkGhizDE9WGDmKqDxaU95qeNJc7XR3hRi7JzZDuZQQnHwoxbSSk4pQ30vbUjIMSVI19z7nlqhcj4awHMmALtGp92mkt6zQbrUwoCfwz0ecnwV3LTbyVgo8CC1EF3u8FUvy1mlzk7PL2CyGYuGZJRibouHWwQt_92eupyaNjFTDsACrFnJOxTxCM5DYZ8jEZcpsMuU9G5X38i6dcNb76Xq_s_H_Zn3dsF2xMM9zF5LUscO9jsglCTYCk_5b4DROB0vk |
CitedBy_id | crossref_primary_10_2147_DDDT_S487496 crossref_primary_10_1016_j_lfs_2024_122720 crossref_primary_10_3389_fcimb_2024_1363276 crossref_primary_10_1080_0886022X_2024_2411359 crossref_primary_10_1007_s11255_024_04302_3 crossref_primary_10_2147_BCTT_S475860 crossref_primary_10_1186_s12958_024_01208_8 crossref_primary_10_3164_jcbn_23_127 crossref_primary_10_1007_s00604_023_06167_2 crossref_primary_10_1016_j_advms_2025_01_008 crossref_primary_10_1016_j_intimp_2024_113804 crossref_primary_10_1111_imr_13280 crossref_primary_10_1038_s41467_024_45706_0 crossref_primary_10_1016_j_cytogfr_2025_01_003 crossref_primary_10_1186_s40780_024_00330_4 crossref_primary_10_1016_j_biopha_2024_117689 crossref_primary_10_1016_j_jhazmat_2024_134371 crossref_primary_10_4103_jmau_jmau_86_24 crossref_primary_10_1007_s40620_024_01927_6 crossref_primary_10_3390_antiox12091728 crossref_primary_10_1016_j_freeradbiomed_2024_10_296 crossref_primary_10_3390_ijms25116239 crossref_primary_10_1021_acs_jproteome_4c00939 crossref_primary_10_3390_ijms24087608 crossref_primary_10_2147_JIR_S506964 crossref_primary_10_1016_j_xphs_2023_11_018 crossref_primary_10_3390_v15122373 crossref_primary_10_1186_s12935_025_03681_6 |
Cites_doi | 10.1038/s41581-018-0052-0 10.1080/0886022X.2018.1532910 10.3390/ijms222413304 10.1016/j.kint.2017.06.030 10.1016/j.semnephrol.2020.01.002 10.1016/j.chembiol.2020.03.016 10.2147/JEP.S267383 10.3390/ijms17101681 10.1038/s41419-020-2256-z 10.1155/2014/967826 10.1681/ASN.2014030262 10.1038/s41418-022-01008-w 10.1083/jcb.202105043 10.1007/s40620-017-0392-z 10.1038/s41580-020-00324-8 10.1155/2020/2851349 10.1016/j.biocel.2012.08.016 10.1002/ptr.6507 10.1016/S0891-5849(99)00177-X 10.1146/annurev-med-050214-013407 10.1155/2020/7912763 10.1093/jn/134.3.489 10.1186/1477-5956-6-15 10.1038/aps.2010.186 10.1186/s12885-019-6233-9 10.3389/fphar.2019.00376 10.4143/crt.2016.572 10.1007/s00011-019-01258-4 10.1016/S0270-9295(03)00089-5 10.1038/s41419-022-04527-z |
ContentType | Journal Article |
Copyright | 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 The Author(s) |
Copyright_xml | – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 The Author(s) |
DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1080/13510002.2022.2152607 |
DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | REDOX REPORT |
EISSN | 1743-2928 |
ExternalDocumentID | oai_doaj_org_article_f43e75c93c74488f8c4972864a251fa3 PMC9879199 36692085 10_1080_13510002_2022_2152607 2152607 |
Genre | Research Article Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 82270713 funderid: 10.13039/501100001809 – fundername: Gusu Health Talent Project of Suzhou grantid: GSWS2019017; GSWS2019052; GSW2020049 – fundername: Key Disease Project of Suzhou Health Commission grantid: LCZX201908 – fundername: Key Laboratory Foundation of Structural Deformities in Children of Suzhou grantid: SZS2022018 – fundername: Natural Science Foundation of Jiangsu Province of China grantid: BK20191176; SYS2019090 |
GroupedDBID | --- 002 0YH 123 29P 36B 4.4 53G ABDBF ABFIM ACUHS ADCVX AENEX AIJEM ALMA_UNASSIGNED_HOLDINGS CS3 DGEBU DU5 E01 EAP EBD EBS EDH EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ H13 HCLVR HZ~ M4Z MV1 OK1 P2P P76 P7B RPM SV3 TDBHL TFL TFT TFW TUS AAYXX CITATION AAOAP AAXYE ABTAA ACQMU ADGTR AFDYB APNXG AURDB BFWEY CGR CUY CVF CWRZV ECM EIF EJD HGUVV JEPSP M46 NPM OWHGL PCLFJ RIG TTHFI Z0Y 7X8 5PM |
ID | FETCH-LOGICAL-c600t-30305e4c086d89c3fd0133f2a9310f73a162cf543da60f61b3de359b3519384d3 |
IEDL.DBID | 0YH |
ISSN | 1351-0002 1743-2928 |
IngestDate | Wed Aug 27 01:32:03 EDT 2025 Thu Aug 21 18:38:34 EDT 2025 Thu Jul 10 23:46:42 EDT 2025 Thu Jan 02 22:54:50 EST 2025 Tue Jul 01 00:49:48 EDT 2025 Thu Apr 24 23:08:36 EDT 2025 Wed Dec 25 09:05:12 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | JAK/STAT3 ferroptosis Acute kidney injury Baicalein apoptosis Glutathione metabolism Cisplatin renal tubular |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c600t-30305e4c086d89c3fd0133f2a9310f73a162cf543da60f61b3de359b3519384d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Co-first authors |
ORCID | 0000-0002-0917-7449 |
OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/13510002.2022.2152607 |
PMID | 36692085 |
PQID | 2769375260 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f43e75c93c74488f8c4972864a251fa3 proquest_miscellaneous_2769375260 pubmed_primary_36692085 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9879199 crossref_citationtrail_10_1080_13510002_2022_2152607 informaworld_taylorfrancis_310_1080_13510002_2022_2152607 crossref_primary_10_1080_13510002_2022_2152607 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-31 |
PublicationDateYYYYMMDD | 2023-12-31 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-31 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Redox report : communications in free radical research |
PublicationTitleAlternate | Redox Rep |
PublicationYear | 2023 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_4_4_1 e_1_3_4_3_1 e_1_3_4_2_1 e_1_3_4_9_1 e_1_3_4_8_1 e_1_3_4_7_1 e_1_3_4_20_1 e_1_3_4_6_1 e_1_3_4_5_1 e_1_3_4_23_1 e_1_3_4_24_1 Ursini F (e_1_3_4_31_1); 2020 e_1_3_4_22_1 e_1_3_4_27_1 e_1_3_4_28_1 e_1_3_4_25_1 e_1_3_4_26_1 e_1_3_4_29_1 Doke T (e_1_3_4_21_1) 2022 e_1_3_4_30_1 e_1_3_4_12_1 e_1_3_4_13_1 e_1_3_4_34_1 e_1_3_4_10_1 e_1_3_4_33_1 e_1_3_4_11_1 e_1_3_4_32_1 e_1_3_4_16_1 e_1_3_4_14_1 e_1_3_4_15_1 Sreekumar PG (e_1_3_4_17_1) 2021; 10 e_1_3_4_18_1 e_1_3_4_19_1 |
References_xml | – ident: e_1_3_4_2_1 doi: 10.1038/s41581-018-0052-0 – ident: e_1_3_4_26_1 doi: 10.1080/0886022X.2018.1532910 – ident: e_1_3_4_22_1 doi: 10.3390/ijms222413304 – ident: e_1_3_4_27_1 doi: 10.1016/j.kint.2017.06.030 – ident: e_1_3_4_30_1 doi: 10.1016/j.semnephrol.2020.01.002 – ident: e_1_3_4_15_1 doi: 10.1016/j.chembiol.2020.03.016 – ident: e_1_3_4_28_1 doi: 10.2147/JEP.S267383 – ident: e_1_3_4_34_1 doi: 10.3390/ijms17101681 – ident: e_1_3_4_12_1 doi: 10.1038/s41419-020-2256-z – ident: e_1_3_4_4_1 doi: 10.1155/2014/967826 – ident: e_1_3_4_16_1 doi: 10.1681/ASN.2014030262 – volume: 2020 start-page: 175 ident: e_1_3_4_31_1 article-title: Lipid peroxidation and ferroptosis: the role of GSH and GPx4 publication-title: Free Radic Biol Med – ident: e_1_3_4_11_1 doi: 10.1038/s41418-022-01008-w – ident: e_1_3_4_10_1 doi: 10.1083/jcb.202105043 – ident: e_1_3_4_14_1 doi: 10.1007/s40620-017-0392-z – ident: e_1_3_4_29_1 doi: 10.1038/s41580-020-00324-8 – ident: e_1_3_4_8_1 doi: 10.1155/2020/2851349 – ident: e_1_3_4_23_1 doi: 10.1016/j.biocel.2012.08.016 – ident: e_1_3_4_9_1 doi: 10.1002/ptr.6507 – ident: e_1_3_4_18_1 doi: 10.1016/S0891-5849(99)00177-X – ident: e_1_3_4_3_1 doi: 10.1146/annurev-med-050214-013407 – ident: e_1_3_4_7_1 doi: 10.1155/2020/7912763 – volume: 10 issue: 5 year: 2021 ident: e_1_3_4_17_1 article-title: Glutathione metabolism and the novel role of mitochondrial GSH in retinal degeneration publication-title: Antioxidants (Basel, Switzerland) – ident: e_1_3_4_20_1 doi: 10.1093/jn/134.3.489 – ident: e_1_3_4_19_1 doi: 10.1186/1477-5956-6-15 – ident: e_1_3_4_24_1 doi: 10.1038/aps.2010.186 – ident: e_1_3_4_5_1 doi: 10.1186/s12885-019-6233-9 – ident: e_1_3_4_33_1 doi: 10.3389/fphar.2019.00376 – ident: e_1_3_4_13_1 doi: 10.4143/crt.2016.572 – ident: e_1_3_4_32_1 doi: 10.1007/s00011-019-01258-4 – ident: e_1_3_4_6_1 doi: 10.1016/S0270-9295(03)00089-5 – ident: e_1_3_4_25_1 doi: 10.1038/s41419-022-04527-z – start-page: S0962 year: 2022 ident: e_1_3_4_21_1 article-title: The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development publication-title: Trends Cell Biol |
SSID | ssj0003698 |
Score | 2.4929874 |
Snippet | Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and... ABSTRACTRenal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal... |
SourceID | doaj pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2152607 |
SubjectTerms | Acute kidney injury Acute Kidney Injury - chemically induced Acute Kidney Injury - metabolism Animals Apoptosis Baicalein Cisplatin Ferroptosis Glutathione - metabolism JAK/STAT3 Kidney - metabolism Mice renal tubular |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pa9swFBajh7HL2NL9yNYNDUZP9Rpbsiwdu7GuDDp2aKE3IcvSZkjsEDuM_Pd9T5azpAxy2cVgRQIp77Pfe_LT9xHy0YELzmxqEgXhb8JZphJZliaxKas8c8LJwLZ__UNc3fLvd_ndjtQX1oQN9MDDH3fuOXNFbhWzBWQS0kvLVZFJwQ14Zm8Czyf4vDGZiu9gJoIKLsrP4bnpbDy7I2fn2IZNkBtmcAH_JVBLdscrBfL-B9Sl_wpAH9ZR7jimy2fkaYwo6cWwkufkkWsm5PiigWx6saGnNNR4hs3zCXl8HT-lT8jpz4G0enNGb_6ewerOwogtnfXmmLTfAJxYo9g2ji5cD6iZ192CrtyfGjcFaaR66KAFJ9Kvy_XcUfwi0FHzy9QQgFJbd0usumuSuqkATRU1y3bZt10NfZqKerdaxfsX5Pby682XqyTKNCQWoqU-YfjOcNxCclRJZZmvIKxkPjMKQkdfMJOKzPqcs8qImRdpySrHclWiNCCTvGIvyVEDS3hNqORWoukcZIEcDF7aXElVlJiYijKdTQkfzaRt5DBHKY25TiPV6WhdjdbV0bpT8mk7bDmQeBwa8BkxsO2MHNyhAZCpIzL1IWROidpFkO7DFowf9FI0OzCBDyPcNDzvaDLTuHbd6QzFKwvsNCWvBvhtp8mEUKi5OiXFHjD31rH_S1P_DpziShYqVerN_1j4W_IE1sIGOswTctSv1u4dhG59-T48pffbnToh priority: 102 providerName: Directory of Open Access Journals |
Title | Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis |
URI | https://www.tandfonline.com/doi/abs/10.1080/13510002.2022.2152607 https://www.ncbi.nlm.nih.gov/pubmed/36692085 https://www.proquest.com/docview/2769375260 https://pubmed.ncbi.nlm.nih.gov/PMC9879199 https://doaj.org/article/f43e75c93c74488f8c4972864a251fa3 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA9yB-KL6J4f9XSJIPd01W2Tps3jrrouwokPd6BPJU2Ts7DbLm0X2f_-ZtIPbw_lHnwptE3KlPlNMpNMfkPIOwNTcKgD5Utwf33OQuknWaZ8HbDcMiNM4tj2L76J1RX_-iMasgmbPq0SY2jbEUW4sRqNW2XNkBH3AYvKoSVDdBfCBWYggefJj0NEK0B69nM1DsZMuHK42AUPUIfDIZ5_feZgenIs_nc4TP_mid5NqLw1Qy2fkMe9a0nnHRaekgemnJCTeQlh9WZPz6hL9nSr6BPy8KLfU5-Qs-8de_X-nF7-OYzVnLseI6_1_oRUXwClmKxYlYZuTAvwWRfNhtbmd4Grg7TnfGjgCQrS7rLd2lDcGmioulYFeKJUF80W0-9KvyhzgFVO1bbatlVTQJsyp9bUdX__jFwtP19-XPl9vQZfg9vU-gwHD8M1REl5IjWzOfiXzIZKgg9pY6YCEWobcZYrMbMiyFhuWCQzrBHIEp6z5-SohF94SWjCdYKqMxAOch3zTEcykXGGEarIgplH-KCmVPdk5lhTY50GPefpoN0UtZv22vXI-7HbtmPzuK_DAjEwNkYybvegqq_T3rZTy5mJIy0ZCArjoU00l3GYCK7AebSKeUTeRlDaurUY2xVOSdk9Arwd4JaC4aPKVGmqXZOGWMUyxkYeedHBbxSTCSGx-KpH4gNgHvzH4Zuy-OXIxWUSy0DKV_8h8yl5BLeso8N8TY7aemfegOvWZlNnnFNyPF98WiynbgHkBiXwOfo |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfQkIAXBB0f5dNIaE8LNLHjxI8DMQqsEw-dNJ4sx7FHpDapmlSo_z13zgftBNoDL5GS2NFFd-e7s-9-R8hbCyY4MqEOJLi_AWeRDNIs04EJWe6YFTb1aPuzczG94F8v48udWhhMq8QY2rVAEX6tRuXGzeg-Je49dpVDVYbwLoILmCCBBeW3YzC-2L5h8mM6rMZM-H64OAUrqKO-iudfn9mzTx7G_xqI6d9c0esZlTsm6vQBud_5lvSkFYaH5JYtR-TwpIS4ermlR9Rne_pt9BG5M-sO1Ufk6HsLX709pvM_1Vj1sZ8xAFtvD0n1GcQUsxWr0tKlbUB-FkW9pGv7q8DtQdqBPtTwBAlpNtlmYSmeDdRUX-kCXFFqinqF-XdlUJQ5yFVO9apaNVVdwJgyp86u1939I3Jx-mn-cRp0DRsCA35TEzBcPSw3ECblqTTM5eBgMhdpCU6kS5gORWRczFmuxcSJMGO5ZbHMsEkgS3nOHpODEn7hKaEpNymyzkI8yE3CMxPLVCYZhqgiCydjwns2KdOhmWNTjYUKO9DTnrsKuas67o7Ju2HaqoXzuGnCB5SBYTCicfsH1fpKdcqtHGc2iY1kQCgsiC41XCZRKrgG79FpNiZyV4JU4zdjXNs5RbEbCHjTi5sCzUeW6dJWm1pF2MYywUFj8qQVv4FMJoTE7qtjkuwJ5t5_7L8pi58eXVymiQylfPYfNL8md6fz2Zk6-3L-7Tm5B69Yi435ghw06419CX5ck73yivob8fQ7Bw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDBaGDih2GbZ0j-ypAUNP9RZbsiwdu0eWPVr00ALbSZBlqTOQ2EHsYMi_HynbWVNs6GGXALalgAY_iqRMfSTktQMXnNjYRArC34izREUyz01kY1Z45oSTgW3_5FTMLviX7-lQTdj0ZZWYQ_uOKCKs1Wjcy8IPFXFvsakcWjJkdwn8gAcSeJ78dirB1wOkJz9m28WYidAOF6fgAepkOMTzr7_ZcU-Bxf8ah-nfItHrBZVXPNT0Hrnbh5b0uMPCfXLLVSNycFxBWr3Y0EMaij3DLvqI7J_039RH5PCsY6_eHNHzP4exmqMwY8trvTkg9SdAKRYr1pWjC9cCfOZls6Ar96vE3UHacz40cAcFadf5eu4ofhpoqLk0JUSi1JbNEsvvqqisCoBVQc2yXrZ1U8KYqqDerVb99QNyMf14_n4W9f0aIgthUxsxXDwct5AlFVJZ5guIL5lPjIIY0mfMxCKxPuWsMGLiRZyzwrFU5dgjkElesIdkr4JXeEyo5Fai6hykg9xmPLepkirLMUMVeTwZEz6oSduezBx7asx13HOeDtrVqF3da3dM3mynLTs2j5smvEMMbAcjGXe4Ua8udW_b2nPmstQqBoLCeuil5SpLpOAGgkdv2JioqwjSbdiL8V3jFM1uEODVADcNho8qM5Wr141OsItlhoPG5FEHv62YTAiFzVfHJNsB5s577D6pyp-BXFzJTMVKPfkPmV-S_bMPU_3t8-nXp-QOPGEdM-Yzsteu1u45RHFt_iLY6W_hWTo5 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glutathione+metabolism+rewiring+protects+renal+tubule+cells+against+cisplatin-induced+apoptosis+and+ferroptosis&rft.jtitle=Redox+report+%3A+communications+in+free+radical+research&rft.au=Dong%2C+Xing-Qiang&rft.au=Chu%2C+Li-Kai&rft.au=Cao%2C+Xu&rft.au=Xiong%2C+Qian-Wei&rft.date=2023-12-31&rft.issn=1351-0002&rft.eissn=1743-2928&rft.volume=28&rft.issue=1&rft_id=info:doi/10.1080%2F13510002.2022.2152607&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_13510002_2022_2152607 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-0002&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-0002&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-0002&client=summon |